The relationship between metabolic dysfunction-associated fatty liver disease and hormonal disorders in children: A literature review
View abstract on PubMed
Summary
This summary is machine-generated.Hormonal imbalances like thyroid dysfunction, insulin resistance, and low vitamin D are common in children with fatty liver disease. Weight loss can improve these issues, highlighting the need for endocrine care.
Area Of Science
- Pediatric Endocrinology
- Hepatology
- Metabolic Disorders
Background
- Metabolic dysfunction-associated fatty liver disease (MAFLD) is increasingly prevalent in children.
- MAFLD is linked to various metabolic and hepatic abnormalities.
- Hormonal disturbances may play a significant role in pediatric MAFLD progression.
Purpose Of The Study
- To review current evidence on hormonal disturbances in pediatric MAFLD.
- To examine the relationship between hormonal changes and liver/metabolic issues.
- To assess the impact of interventions on these hormonal disturbances.
Main Methods
- Comprehensive literature search of PubMed, Scopus, and Web of Science (2015-2025).
- Inclusion of studies on children (0-18 years) with confirmed MAFLD.
- Exclusion of adult studies, small case series, and articles lacking endocrine data.
Main Results
- High prevalence of subclinical hypothyroidism (18-42%), insulin resistance (>65%), low testosterone/SHBG in boys, and vitamin D deficiency (55-70%).
- Hormonal disturbances correlated with elevated liver enzymes and steatosis severity.
- Weight reduction (7-10%) improved insulin resistance, thyroid/sex hormones, and vitamin D status.
Conclusions
- Pediatric MAFLD is a multisystem condition influenced by hormonal dysfunction.
- Comprehensive endocrine evaluation is crucial for standard pediatric MAFLD care.
- Further research is needed, especially in younger children, girls, and diverse populations.
Related Concept Videos
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...

